References
1 Kingsmore SF, Cakici JA, Clark MM, et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants[J]. Am J Hum Genet, 2019, 105(4): 719-733. PMID: 31564432. PMCID: PMC6817534. DOI: 10.1016/j.ajhg.2019.08.009.
2 Ceyhan-Birsoy O, Murry JB, Machini K, et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq Project[J]. Am J Hum Genet, 2019, 104(1): 76-93. PMID: 30609409. PMCID: PMC6323417. DOI: 10.1016/j.ajhg.2018.11.016.
3 Jacob J, Kamitsuka M, Clark RH, et al. Etiologies of NICU deaths[J]. Pediatrics, 2015, 135(1): e59-e65. PMID: 25489010. DOI: 10.1542/peds.2014-2967.
4 de Castro MJ, González-Vioque E, Barbosa-Gouveia S, et al. Rapid phenotype-driven gene sequencing with the NeoSeq panel: a diagnostic tool for critically ill newborns with suspected genetic disease[J]. J Clin Med, 2020, 9(8): 2362. PMID: 32718099. PMCID: PMC7464859. DOI: 10.3390/jcm9082362.
5 Xiao F, Yan K, Tang M, et al. Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis[J]. Expert Rev Mol Diagn, 2022, 22(8): 833-840. PMID: 36082848. DOI: 10.1080/14737159.2022.2123704.
6 French CE, Delon I, Dolling H, et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children[J]. Intensive Care Med, 2019, 45(5): 627-636. PMID: 30847515. PMCID: PMC6483967. DOI: 10.1007/s00134-019-05552-x.
7 Wang H, Lu Y, Dong X, et al. Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China[J]. Hum Genet, 2020, 139(4): 473-482. PMID: 31965297. DOI: 10.1007/s00439-019-02103-8.
8 Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
9 陈宾, 董欣然, 王慧君, 等. 复旦大学附属儿科医院高通量测序数据一体化全流程闭环分析系统及临床应用案例分析[J]. 中国循证儿科杂志, 2022, 17(3): 202-209. DOI: 10.3969/j.issn.1673-5501.2022.03.006.
10 Faienza MF, Giordani L, Ferraris M, et al. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link?[J]. Pediatr Cardiol, 2009, 30(7): 1012-1015. PMID: 19582499. DOI: 10.1007/s00246-009-9473-7.
11 Chen H, Li X, Liu X, et al. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort[J]. Orphanet J Rare Dis, 2019, 14(1): 29. PMID: 30732632. PMCID: PMC6367752. DOI: 10.1186/s13023-019-1010-z.
12 Woo HY, Oh C, Han JW, et al. Clinical features of children with Haddad syndrome: a single-center experience[J]. J Pediatr Surg, 2020, 55(3): 387-392. PMID: 30850150. DOI: 10.1016/j.jpedsurg.2019.01.066.
13 Yang L, Liu X, Li Z, et al. Genetic aetiology of early infant deaths in a neonatal intensive care unit[J]. J Med Genet, 2020, 57(3): 169-177. PMID: 31501239. DOI: 10.1136/jmedgenet-2019-106221.
14 Zhu T, Gong X, Bei F, et al. Application of next-generation sequencing for genetic diagnosis in neonatal intensive care units: results of a multicenter study in China[J]. Front Genet, 2020, 11: 565078. PMID: 33240318. PMCID: PMC7677510. DOI: 10.3389/fgene.2020.565078.
15 齐志业, 段江, 贺湘英, 等. 全外显子组测序在危重症新生儿单基因遗传病中的临床应用[J]. 中国当代儿科杂志, 2019, 21(7): 640-643. PMID: 31315761. PMCID: PMC7389093. DOI: 10.7499/j.issn.1008-8830.2019.07.005.
16 陈玉兰, 张又祥, 杨秀芳, 等. 全外显子测序技术在危重症新生儿遗传病中的应用价值[J]. 中国当代儿科杂志, 2020, 22(12): 1261-1266. PMID: 33327995. PMCID: PMC7735930. DOI: 10.7499/j.issn.1008-8830.2007109.
17 Dimmock DP, Clark MM, Gaughran M, et al. An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm[J]. Am J Hum Genet, 2020, 107(5): 942-952. PMID: 33157007. PMCID: PMC7675004. DOI: 10.1016/j.ajhg.2020.10.003.